Evaluation of γ-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane

References

• Amidon GL, Lennernaes H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.
   PubMed Web of Science ®Google Scholar
• Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int J Pharm 2011;420:1–10.
   PubMed Web of Science ®Google Scholar
• Hymas RV, Ho NFH, Higuchi WI. Transport of a lipophilic ionizable permeant (capric acid) across a lipophilic membrane (silicone polymer membrane) from aqueous buffered solutions in the presence of hydroxypropyl-β-cyclodextrin. J Pharm Sci 2012;101:2340–2352.
   PubMed Web of Science ®Google Scholar
• Kokate A, Li X, Jasti B. Effect of drug lipophilicity and ionization on permeability across the buccal mucosa: a technical note. AAPS PharmSciTech 2008;9:501–504.
   PubMed Web of Science ®Google Scholar
• Sridevi S, Diwan PVR. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-beta-cyclodextrin as co-enhancers. Eur J Pharm Biopharm 2002;54:151–154.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm 2001;225:15–30.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Stefansson E. Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug. J Drug Delivery Sci Technol 2007;17:3–9.
   Web of Science ®Google Scholar
• Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645–666.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharmaceut 2007;329:1–11.
   PubMed Web of Science ®Google Scholar
• Figueiras A, Hombach J, Veiga F, Bernkop-Schnürch A. In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery. Eur J Pharm Biopharm 2009;71:339–345.
   PubMed Web of Science ®Google Scholar
• Gupta V, Hwang BH, Doshi N, Mitragotri S. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine. J Control Release 2013;172:541–549.
   PubMed Web of Science ®Google Scholar
• Másson M, Loftsson T, Másson G, Stefánsson E. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release 1999;59:107–118.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Noppe M, Peeters J, Loftsson T. Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins. Int J Pharm 2007;342:250–253.
   PubMed Web of Science ®Google Scholar
• Loftsson T. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer. Pharmazie 2012;67:363–370.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Vogensen SB, Brewster ME, Konraosdottir F. Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci 2007;96:2532–2546.
   PubMed Web of Science ®Google Scholar
• Jansook P, Kurkov SV, Loftsson T. Cyclodextrins as solubilizers: formation of complex aggregates. J Pharm Sci 2010;99:719–729.
   PubMed Web of Science ®Google Scholar
• Messner M, Kurkov SV, Brewster ME, et al. Self-assembly of cyclodextrin complexes: Aggregation of hydrocortisone/cyclodextrin complexes. Int J Pharm 2011;407:174–183.
   PubMed Web of Science ®Google Scholar
• Beig A, Miller JM, Dahan A. The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off. Eur J Pharm Biopharm 2013;85:1293–1299.
   PubMed Web of Science ®Google Scholar
• Dahan A, Miller JM, Hoffman A, et al. The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone. J Pharm Sci 2010;99:2739–2749.
   PubMed Web of Science ®Google Scholar
• Hovgaard L, Brondsted H. Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins. Pharm Res 1995;12:1328–1332.
   PubMed Web of Science ®Google Scholar
• Kuang H-f, Tu C-b, Yang X-h, et al. Transport research of ibuprofen/HP-β-CD system in the Caco-2 monolayer model. Zhongguo Xinyao Zazhi 2008;17:1037–1041.
   Google Scholar
• Velický M, Tam KY, Dryfe RAW. In situ artificial membrane permeation assay under hydrodynamic control: correlation between drug in vitro permeability and fraction absorbed in humans. Eur J Pharm Sci 2011;44:299–309.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Konrádsdóttir F, Másson M. Development and evaluation of an artificial membrane for determination of drug availability. Int J Pharm 2006;326:60–68.
   PubMed Web of Science ®Google Scholar
• Mälkiä A, Murtomäki L, Urtti A, Kontturi K. Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties. Eur J Pharm Sci 2004;23:13–47.
   PubMed Web of Science ®Google Scholar
• Mazzobre MF, Román MV, Mourelle AF, Corti HR. Octanol-water partition coefficient of glucose, sucrose, and trehalose. Carbohydr Res 2005;340:1207–1211.
   PubMed Web of Science ®Google Scholar
• Liu X, Testa B, Fahr A. Lipophilicity and its relationship with passive drug permeation. Pharm Res 2011;28:962–977.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. J Pharm Pharmacol 2011;63:1119–1135.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Konradsdottir F, Masson M. Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Die Pharmazie 2006;61:83–89.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 2005;302:18–28.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Konradsdottir F, Masson M. Development of octanol membranes for drug screening. J Inclusion Phenom Macrocyclic Chem 2007;57:613–617.
   Web of Science ®Google Scholar
• González-Gaitano G, Rodríguez P, Isasi JR, et al. The aggregation of cyclodextrins as studied by photon correlation spectroscopy. J Incl Phenom Macrocycl Chem 2002;44:101–105.
   Web of Science ®Google Scholar
• Higuchi T, Connors KA. Phase-solubility techniques. Advan Anal Chem Instr 1965;4:117–212.
   Google Scholar
• Al Omari AA, Al Omari MM, Badwan AA, Al-Sou’od KA. Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state. J Pharm Biomed Anal 2011;54:503–509.
   PubMed Web of Science ®Google Scholar
• Messner M, Kurkov SV, Palazón MM, et al. Self-assembly of cyclodextrin complexes: effect of temperature, agitation and media composition on aggregation. Int J Pharm 2011;419:322–328.
   PubMed Web of Science ®Google Scholar
• Muankaew C, Jansook P, Stefánsson E, Loftsson T. Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients. Int J Pharm 2014;474:80–90.
   PubMed Web of Science ®Google Scholar
• Tosco P, Rolando B, Fruttero R, et al. Physicochemical profiling of sartans: a detailed study of ionization constants and distribution coefficients. Helvetica Chimica Acta 2008;91:468–482.
   Web of Science ®Google Scholar